FI960540A0 - Eksonukleaasin ja/tai glykosylaasin käyttö antipolymeraasivasta-aineenlisäaineina spesifisyyden lisäämiseksi polymeraasiketjureaktiossa - Google Patents

Eksonukleaasin ja/tai glykosylaasin käyttö antipolymeraasivasta-aineenlisäaineina spesifisyyden lisäämiseksi polymeraasiketjureaktiossa

Info

Publication number
FI960540A0
FI960540A0 FI960540A FI960540A FI960540A0 FI 960540 A0 FI960540 A0 FI 960540A0 FI 960540 A FI960540 A FI 960540A FI 960540 A FI960540 A FI 960540A FI 960540 A0 FI960540 A0 FI 960540A0
Authority
FI
Finland
Prior art keywords
glycosylase
exonuclease
antibody
antipolymerase
additives
Prior art date
Application number
FI960540A
Other languages
English (en)
Swedish (sv)
Other versions
FI960540A (fi
Inventor
John William Hender Sutherland
David Robert Patterson
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Publication of FI960540A0 publication Critical patent/FI960540A0/fi
Publication of FI960540A publication Critical patent/FI960540A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/30Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/319Exonuclease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/50Other enzymatic activities
    • C12Q2521/531Glycosylase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
FI960540A 1995-02-07 1996-02-06 Eksonukleaasin ja/tai glykosylaasin käyttö antipolymeraasivasta-aineenlisäaineina spesifisyyden lisäämiseksi polymeraasiketjureaktiossa FI960540A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38501995A 1995-02-07 1995-02-07

Publications (2)

Publication Number Publication Date
FI960540A0 true FI960540A0 (fi) 1996-02-06
FI960540A FI960540A (fi) 1996-08-08

Family

ID=23519709

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960540A FI960540A (fi) 1995-02-07 1996-02-06 Eksonukleaasin ja/tai glykosylaasin käyttö antipolymeraasivasta-aineenlisäaineina spesifisyyden lisäämiseksi polymeraasiketjureaktiossa

Country Status (15)

Country Link
US (1) US5985619A (fi)
EP (1) EP0726324B1 (fi)
JP (1) JPH08266298A (fi)
KR (1) KR960031627A (fi)
AT (1) ATE201452T1 (fi)
AU (1) AU709788B2 (fi)
CA (1) CA2168712A1 (fi)
DE (1) DE69612885T2 (fi)
DK (1) DK0726324T3 (fi)
ES (1) ES2156978T3 (fi)
FI (1) FI960540A (fi)
GR (1) GR3036391T3 (fi)
NO (1) NO960484L (fi)
PT (1) PT726324E (fi)
SI (1) SI0726324T1 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2292039A1 (en) * 1997-05-28 1998-12-03 The Walter And Eliza Hall Institute Of Medical Research Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
FR2803601A1 (fr) * 2000-01-11 2001-07-13 Inst Nat Sante Rech Med Utilisation de l'exonuclease iii dans des reactions d'amplification par polymerase de fragments d'adn
EP1275735A1 (en) 2001-07-11 2003-01-15 Roche Diagnostics GmbH Composition and method for hot start nucleic acid amplification
US20040152072A1 (en) * 2002-07-30 2004-08-05 Invitrogen Corporation Reverse transcription
CA2464874C (en) 2003-05-01 2013-10-22 Veridex, Llc Intraoperative lymph node assay
BRPI0510645A (pt) * 2004-06-04 2007-11-20 Veridex Llc diagnóstico ou prognóstico do progresso do cáncer de mama, composição compreendendo conjuntos de iniciador/sonda de ácido nucléico e kit para análise de linfonodo intraoperativo
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
EP1989324B1 (en) * 2006-02-27 2011-05-18 Roche Diagnostics GmbH Pcr hot start by magnesium sequestration
EP2019687B1 (en) 2006-03-29 2014-03-19 Merial Limited Vaccine against streptococci
CA2658520C (en) 2008-03-19 2016-11-08 F. Hoffmann-La Roche Ag Nucleic acid amplification in the presence of modified randomers
EP2990487A1 (en) 2008-05-08 2016-03-02 Asuragen, INC. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
US7910720B2 (en) 2008-09-09 2011-03-22 Roche Diagnostics Operations, Inc. Polyanion for improved nucleic acid amplification
CA2762986C (en) 2009-05-22 2018-03-06 Asuragen, Inc. Mirna biomarkers of prostate disease
IL206810A (en) 2009-07-08 2015-07-30 Janssen Diagnostics Llc Methods for identifying melanoma and kits for using these methods
WO2011025919A1 (en) 2009-08-28 2011-03-03 Asuragen, Inc. Mirna biomarkers of lung disease
EP2640851A2 (en) 2010-11-17 2013-09-25 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2971132B1 (en) 2013-03-15 2020-05-06 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
EP2971149B1 (en) 2013-03-15 2018-05-09 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
EP3425066A1 (en) 2014-01-05 2019-01-09 Biomirna Holdings Ltd. Lung cancer determinations using mirna
WO2015120382A1 (en) 2014-02-07 2015-08-13 The Johns Hopkins University Predicting response to epigenetic drug therapy
GB201414745D0 (en) 2014-08-19 2014-10-01 Articzymes As Exonucleases
WO2016094330A2 (en) 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
EP3292214A1 (en) 2015-05-04 2018-03-14 Academisch Medisch Centrum Method of quantifying mirnas using normalization
US10081829B1 (en) 2017-06-13 2018-09-25 Genetics Research, Llc Detection of targeted sequence regions
JP2019198259A (ja) * 2018-05-15 2019-11-21 株式会社島津製作所 1ステップrt−pcr法
WO2020172362A1 (en) * 2019-02-20 2020-08-27 Genetics Research, Llc Regulated multiplex reactions in a single tube
EP3719144A1 (en) 2019-04-05 2020-10-07 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Mir-151a-3p as an universal endogenous control for exosome cargo normalization
US20220267857A1 (en) 2019-07-19 2022-08-25 Fundación Para La Investigación Biomédikca Del Hospital Universitario La Paz (Fibhulp) Method for determining the response to treatment of a patient affected by non-small cell lung carcinoma (nsclc)
WO2021120095A1 (zh) * 2019-12-19 2021-06-24 深圳华大生命科学研究院 抗聚合酶的单克隆抗体及其应用
WO2023146243A1 (ko) * 2022-01-26 2023-08-03 주식회사 씨젠 샘플 내 타겟 핵산을 검출하는 방법
CN116773291B (zh) * 2023-03-31 2024-04-19 艾普拜生物科技(苏州)有限公司 一种石蜡切片dna预处理试剂及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0540693T3 (da) * 1990-07-24 1999-09-13 Hoffmann La Roche Reduktion af ikke-specifik amplifikation under in vitro-nukleinsyreamplifikation under anvendelse af modificerede nukleinsy
DE69128520T2 (de) * 1990-10-31 1998-07-09 Tosoh Corp Verfahren zum Nachweis oder Quantifizierung von Zielnukleinsäuren
CA2101119A1 (en) * 1992-08-17 1994-02-18 George T. Walker Exonuclease decontamination method
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
US5605796A (en) * 1994-07-19 1997-02-25 Behringwerke Ag Method for preventing amplification of nucleic acid contaminants in amplification mixtures using nuclease-receptor conjugates

Also Published As

Publication number Publication date
ATE201452T1 (de) 2001-06-15
EP0726324B1 (en) 2001-05-23
FI960540A (fi) 1996-08-08
JPH08266298A (ja) 1996-10-15
US5985619A (en) 1999-11-16
PT726324E (pt) 2001-08-30
DE69612885D1 (de) 2001-06-28
DK0726324T3 (da) 2001-07-30
EP0726324A3 (en) 1996-11-27
EP0726324A2 (en) 1996-08-14
CA2168712A1 (en) 1996-08-08
DE69612885T2 (de) 2001-09-13
NO960484L (no) 1996-08-08
ES2156978T3 (es) 2001-08-01
SI0726324T1 (en) 2001-12-31
GR3036391T3 (en) 2001-11-30
NO960484D0 (no) 1996-02-06
AU4339196A (en) 1996-08-15
AU709788B2 (en) 1999-09-09
KR960031627A (ko) 1996-09-17

Similar Documents

Publication Publication Date Title
FI960540A (fi) Eksonukleaasin ja/tai glykosylaasin käyttö antipolymeraasivasta-aineenlisäaineina spesifisyyden lisäämiseksi polymeraasiketjureaktiossa
ATE207543T1 (de) Isotherme amplifikation von nukleinsäuren durch strangverdrängung
ATE307898T1 (de) Verfahren zur nukleinsäurenamplifizierung, zusammensetzung und kit
PT669401E (pt) Amplificacao de sequencias compridas de acidos nucleicos
EA200100402A1 (ru) Способы амплификации и секвенирования нуклеиновых кислот
ATE443136T1 (de) Methode für dna synthese
DE60034396D1 (de) Reaktionsgemisch und Verfahren für RT-PCR mittels einer homopolymeren Nukleinsäure
DE69532984D1 (de) Verfahren zur Koamplifikation einer Zielnukleinsäure unter Versendung eines Volumenabscheidungsmittel in der Reaktionszusammensetzung, Testsatz und Testvorrichtung
NO962062L (no) Fremgangsmåte for polymerasekjede-reaksjons preamplifikasjons sterilisering ved eksonukleaser i nærvær av fosforotioaterte primere
DE69837913D1 (de) Verfahren zur vervielfältigung von nukleinsäure
ATE220426T1 (de) Verfahren zur direkten, exponentiellen amplifikation und sequenzierung von dna-molekülen und seine anwendung
ATE440147T1 (de) Erhíhung der spezifität von nukleinsäureamplifizierungen durch trägernukleinsäuren
EP0751226A3 (en) Process for amplifying nucleic acid sequences
ATE123315T1 (de) Verfahren zur reinigung, vervielfachung und zum nachweis einer nukleinsäure.
ATE456669T1 (de) Verfahren zur quantifizierung von nukleinsäuren